Merck wins docs from Wyeth ahead of hearing on reopening Prevnar 13 trial

Allens 2019-08-30 10:51 pm By Cat Fredenburgh | Melbourne

Please login to bookmark

Merck Sharp & Dohme has emerged victorious in a battle over documents with Wyeth, as the parties gear up for a hearing on Wyeth’s request to reopen a trial over three patents for its Prevnar 13 pneumococcal vaccine.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au